Amneal Pharmaceuticals of New York, LLC is recalling 2,784 bottles of Methylergonovine Maleate Tablets, USP (0.2mg) because the drug failed dissolution testing. This means the tablets may not dissolve at the required rate in the body, which could potentially reduce the effectiveness of the medication. The recall affects 12-count prescription bottles used primarily to help control bleeding after childbirth.
If the medication fails to dissolve properly, it may not be absorbed into the bloodstream at the correct dosage, which could lead to a loss of efficacy in managing postpartum bleeding. No specific injuries or incidents have been reported to date regarding this issue.
You have 2 options:
Distributed by: Amneal Pharmaceuticals, LLC, Bridgewater, NJ 08807; Product ID 206839.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.